Received Jul 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TD | TD ADSORBED (TENIVAC) | SANOFI PASTEUR | UNK | U7927AA | IM / LA |
About 2 to 3 weeks after the vaccine administration, the patient reported symptoms consisting of progressively worsening right shoulder, deltoid and humerus pain. It started out as a mild soreness, but then evolved into much more severe pain with reduced range of motion, and paresthesias radiating distally into the wrist and hand. She also reported some pain in the parascapular region on the right side. She denied any bruising or swelling or direct trauma to the area and also there was no history of heavy exertion surrounding the time of the development of her symptoms. There were no fevers, chills or night sweats. Initial laboratory findings did not demonstrate any signs of inflammatory markers. She was referred to pain management and diagnoses of brachial neuritis and possible Parsonage-Turner syndrome were entertained. She was referred to physical therapy and acupuncture, which has helped to some degree. She continues with treatment, and also experiences persistent symptoms and functional impairment in the right upper extremity.
None.
None.
None.
Codeine, epinephrine.
10/17/2024: C-reactive protein, ESR, CBC, chemistry panel. No significant abnormalities. 11/12/2024 right shoulder MRI: Subscapularis and deep myotendinous junction strain. Configuration of the acromioclavicular joint may result in impingement. Bicipital tendinitis. High-grade sprain versus partial tear or adhesive capsulitis of the anterior aspect of the inferior humeral capsule. Degeneration through the anterior labrum in the mid to inferior aspect versus tear and scarring.